$1.14
-0.05[-4.20%]
At close: May 6
$1.14
0[0.00%]
After Hours: 5:46PM EDT
Adaptimmune Therapeutics
(NASDAQ:ADAP)Adaptimmune Therapeutics Stock (NASDAQ:ADAP), Earnings Estimates, EPS, and Revenue
Adaptimmune Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 15
EPS Estimate
$-0.100
Quarterly Revenue Estimate
$10.7M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$60.3M
Analyze the earnings history of Adaptimmune Therapeutics using advanced sorting and filters.
No data available to display
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
|---|
FAQ
When is Adaptimmune Therapeutics (NASDAQ:ADAP) reporting earnings?
Adaptimmune Therapeutics (ADAP) is scheduled to report earnings on August 7, 2024. The last reported earnings were for reported on March 6, 2024 for Q4.
What were the latest earnings per share (EPS) for Adaptimmune Therapeutics (NASDAQ:ADAP)?
The Actual EPS was $-0.24, which missed the estimate of $-0.10.
What were Adaptimmune Therapeutics’s (NASDAQ:ADAP) revenues?
The Actual Revenue was $231K, which missed the estimate of $20.5M.
Browse earnings estimates, EPS, and revenue on all stocks.